Madrigal Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Madrigal Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-31 | $-4.92 | $-6.91 | 28.8 % |
Jun 2024 | 2024-08-07 | $-7.10 | $-7.54 | 5.84 % |
Mar 2024 | 2024-05-07 | $-7.38 | $-6.28 | -17.5 % |
Dec 2023 | 2024-02-28 | $-5.68 | $-5.28 | -7.58 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-31 | $62.18M | $34.19M | 81.8 % |
Jun 2024 | 2024-08-07 | $14.64M | $4.02M | 264.1 % |
Madrigal Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on October 31, 2024 for Q3.
Madrigal Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on October 31, 2024 for Q3 and the Actual EPS was $-4.92, which beat the estimate of $-6.91.
Madrigal Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on October 31, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.